MétaCan
Menu
Back to cohort
Record W2130643141 · doi:10.1096/fj.07-095398

PYM50028, a novel, orally active, nonpeptide neurotrophic factor inducer, prevents and reverses neuronal damage induced by MPP <sup>+</sup> in mesencephalic neurons and by MPTP in a mouse model of Parkinson's disease

2008· article· en· W2130643141 on OpenAlexaff
Naomi P. Visanji, Antonia Orsi, Tom H. Johnston, Patrick A. Howson, Kimberly Dixon, Noëlle Callizot, Jonathan M. Brotchie, Daryl D. Rees

Bibliographic record

VenueThe FASEB Journal · 2008
Typearticle
Languageen
FieldNeuroscience
TopicNerve injury and regeneration
Canadian institutionsToronto Western Hospital
FundersCure Parkinson’s Trust
KeywordsGlial cell line-derived neurotrophic factorMPTPNeurotrophic factorsSubstantia nigraDopaminergicNeuroprotectionNeurodegenerationNeuroscienceParkinson's diseaseBrain-derived neurotrophic factorChemistryPars compactaPharmacologyDopamineEndocrinologyInternal medicineMedicineBiologyDiseaseReceptor

Abstract

fetched live from OpenAlex

ABSTRACT Many experimental data support the enhancement of neurotrophic factors as a means to modify neurodegeneration in Parkinson's disease. However, the translation of this to the clinic has proven problematic. This is likely due to the complex nature of the surgical gene delivery and cell‐based approaches adopted to deliver proteinaceous neurotrophic factors to targets within the central nervous system. We investigated the ability of a novel, orally active, nonpeptide neurotrophic factor inducer, PYM50028 (Cogane), to restore dopaminergic function after 1‐methyl‐4‐phenylpyridinium (MPP + ) ‐induced damage to mesencephalic neurons in vitro and in 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP) ‐lesioned mice. In rat mesencephalic neurons, administration of PYM50028, either before or after MPP + , significantly prevented and reversed both MPP + ‐induced neuronal atrophy and cell loss. These effects were potent and of a magnitude equivalent to those achieved by a combination of brain‐derived neurotrophic factor (BDNF) and glial‐derived neurotrophic factor (GDNF). Oral admin istration of PYM50028 (10 mg/kg/day for 60 days) to MPTP‐lesioned mice, commencing after a striatal impairment was evident, resulted in a significant elevation of striatal GDNF (297%) and BDNF (511%), and attenuated the loss of striatal dopaminergic transporter levels and dopaminergic neurons in the substantia nigra. PYM50028 did not inhibit monoamine oxidase B in vitro , nor did it alter brain levels of MPP + in vivo . PYM50028 has neuroprotective and neurorestorative potential and is in clinical development for the treat ment of neurodegenerative disorders, including Parkinson's disease.—Visanji, N. P., Orsi, A., Johnston, T. H., Howson, P. A., Dixon, K., Callizot, N., Brotchie, J. M., Rees, D. D. PYM50028, a novel, orally active, nonpeptide neurotrophic factor inducer, prevents and reverses neuronal damage induced by MPP + in mesencephalic neurons and by MPTP in a mouse model of Parkinson's disease. FASEB J. 22, 2488–2497 (2008)

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.078
Threshold uncertainty score0.877

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.001
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.049
GPT teacher head0.261
Teacher spread0.212 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations76
Published2008
Admission routes1
Has abstractyes

Explore more

Same venueThe FASEB JournalSame topicNerve injury and regenerationFrench-language works237,207